SCHEMBL18757473

SCHEMBL18757473

CC(C)(C)NSc1cccc(N)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.41
▸ CASP1 P29466 2/20 0.41
▸ RECQL P46063 1/20 0.41
▸ ALDH1A1 P00352 5/20 0.35
▸ TSHR P16473 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ TDP1 Q9NUW8 2/20 0.34
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ CA7 P43166 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ CA14 Q9ULX7 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ GFER P55789 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21452871 0.77 MAOA (0.42) ALDH1A1MAPK1MEN1MAPTKMT2A
SCHEMBL18758026 0.75 CYP3A4 (0.44) CYP3A4ALDH1A1TSHRMAPK1TDP1
SCHEMBL873511 0.74 SMN1; SMN2 (0.39) CYP3A4ALDH1A1MAPK1MEN1MAPT
SCHEMBL5313141 0.74 CYP3A4 (0.46) CYP3A4CASP1RECQLALDH1A1TSHR
SCHEMBL18757779 0.73 CYP3A4 (0.41) CYP3A4CASP1RECQLALDH1A1TDP1
SCHEMBL19931108 0.73 CYP3A4 (0.41) CYP3A4CASP1RECQLALDH1A1TSHR
SCHEMBL22966843 0.73 ALDH1A1 (0.46) ALDH1A1TSHR
SCHEMBL28303061 0.73 SMN1; SMN2 (0.38) CYP3A4ALDH1A1MAPK1MEN1MAPT
Hydrochloric Acid SCHEMBL28797568 0.73 SMN1; SMN2 (0.38) CYP3A4ALDH1A1MAPK1MEN1MAPT
Hydrochloric Acid SCHEMBL27555401 0.72 HSD17B10 (0.44) CYP3A4CASP1RECQLALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024039829-A1 INHIBITORS OF KIF18A AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2024-02-22 — — WO disclosed
WO-2023212240-A1 COMPOUNDS FOR INHIBITING KIF18A VOLASTRA THERAPEUTICS, INC. (US) 2023-11-02 — — WO disclosed
WO-2022269384-A1 A PROCESS FOR THE DIRECT SYNTHESIS OF FEDRATINIB INTERMEDIATE AMI ORGANICS LTD. (IN) 2022-12-29 — — WO disclosed
WO-2017066428-A1 BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE, INC. (US) 2017-04-20 — — WO disclosed
Send feedback